Medicare Enrolled

Dr. Richard Demera, MD

Allergy & Immunology · Fresno, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
540 E HERNDON AVE STE 101, Fresno, CA 93720
5594310340
In practice since 2006 (20 years)
NPI: 1407816630 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Demera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Demera

Dr. Richard Demera is an allergy & immunology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Demera performed 53,275 Medicare services across 3,253 unique beneficiaries.

Between the years covered by Open Payments, Dr. Demera received a total of $104,058 from 41 pharmaceutical and/or device companies across 958 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Demera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in CA $104,058 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,275
Medicare services
Top 1% in CA for allergy & immunology
3,253
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,664 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 39,285 $30 $50
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
5,088 $3 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
2,047 $68 $124
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,861 $11 $50
Injection, benralizumab, 1 mg 1,710 $131 $190
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,454 $96 $152
Nasal and throat exam with endoscope
A procedure to visually examine the nose and throat using a thin, flexible tube with a camera. This allows for direct visualization of the internal structures of the upper airway.
452 $96 $244
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
446 $22 $65
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
287 $11 $19
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
207 $15 $50
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
195 $82 $153
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
119 $9 $140
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
47 $31 $103
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
36 $13 $45
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $127 $233
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
18 $6 $41
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$104,058
Total received (2018-2024)
Avg $14,865/year across 7 years
Top 8% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
958
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88,051 (84.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,281 (11.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,726 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,241
2023
$33,946
2022
$33,489
2021
$11,393
2020
$5,266
2019
$2,169
2018
$5,555

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$10,259
AstraZeneca Pharmaceuticals LP
$786
GlaxoSmithKline, LLC.
$344
Genentech USA, Inc.
$309
Incyte Corporation
$148
CSL Behring
$88
ABBVIE INC.
$59
Novartis Pharmaceuticals Corporation
$59
BioCryst US Sales Co., LLC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$43
Phathom Pharmaceuticals, Inc.
$40
ALK-Abello, Inc
$21
Optinose US, Inc.
$19
Grifols USA, LLC
$16
Top 3 companies account for 93.0% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$46,535
GlaxoSmithKline, LLC.
$38,873
Genentech USA, Inc.
$5,069
Novartis Pharmaceuticals Corporation
$4,423
AstraZeneca Pharmaceuticals LP
$3,358
GENZYME CORPORATION
$973
Octapharma USA, Inc.
$734
Teva Pharmaceuticals USA, Inc.
$494
Incyte Corporation
$407
Takeda Pharmaceuticals U.S.A., Inc.
$295
Optinose US, Inc.
$260
PFIZER INC.
$226
Grifols USA, LLC
$221
OptiNose US, Inc.
$213
ABBVIE INC.
$191
Amgen Inc.
$188
AbbVie Inc.
$165
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
Blueprint Medicines Corporation
$134
CSL Behring
$126
ALK-Abello, Inc
$115
Sunovion Pharmaceuticals Inc.
$113
kaleo, Inc.
$107
BioCryst US Sales Co., LLC
$97
LEO Pharma Inc.
$76
Carestream Dental, LLC
$59
Bio Products Laboratory USA, Inc.
$50
Phadia US Inc.
$44
Inspire Medical Systems, Inc.
$43
Pharming Healthcare, Inc.
$41
Mylan Specialty L.P.
$40
Phathom Pharmaceuticals, Inc.
$40
Kaleo, Inc.
$31
Genentech, Inc.
$29
Covis Pharma GmBH
$26
Aimmune Therapeutics, Inc.
$21
BioCryst Pharmaceuticals, Inc.
$21
AIMMUNE THERAPEUTICS, INC.
$19
IDORSIA PHARMACEUTICALS US INC
$16
Merck Sharp & Dohme Corporation
$12
Shire North American Group Inc
$12
Top 3 companies account for 86.9% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ALVESCO · ANORO · ASMANEX · AUVI-Q · AYVAKIT · AirDuo Digihaler · ArmonAir Digihaler · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · EUCRISA · FARXIGA · FASENRA · FIRAZYR · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ICLUSIG · INSPIRE · ImmunoCAP · LONHALA MAGNAIR · MOTEGRITY · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PAZEO · ProAir Digihaler · Prolastin-C Liquid · QUVIVIQ · QVAR · RINVOQ · RUCONEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · VOQUEZNA · XOLAIR · Xembify · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for allergy & immunology in CA.

Looking for an allergy & immunology specialist in Fresno?
Compare allergy & immunologists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
10
Per 100K population
1.0
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Demera is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 8% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Demera experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Demera performed 39,285 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Demera receive payments from pharmaceutical companies?
Yes. Dr. Demera received a total of $104,058 from 41 companies across 958 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demera's costs compare to other allergy & immunologists in Fresno?
Dr. Demera's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →